Category: Press Releases

Jubilant Biosys Limited to add Drug Discovery & Preclinical Development capabilities in Biologics and Antibody Drug Conjugate

Jubilant Biosys announce strategic joint venture with Pierre Fabre to acquire its R&D centre in France, to enter into Biologics (mABs) and ADCs

Jubilant Biosys Limited announced today, an expansion of its facilities to support its discovery chemistry and in-vitro ADME Service offerings.

Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer

New Haven, CT. & Bengaluru, India—Today, Jubilant Biosys and Yale University have announced a research collaboration for multiple small molecule research programs.

Jubilant Biosys Limited (“Biosys”), a wholly owned subsidiary of Jubilant Life Sciences Limited, today announced completion of the merger with its sister company Jubilant Chemsys Limited, based in Noida, India. The combined entities will now operate as Jubilant Biosys Limited.

“Company formation is one of our core activities at Frazier, and Jubilant has been a key part of several of our early-stage companies” Daniel Estes, Ph.D., General Partner on the Frazier Life Sciences team.

Due to growing customer demand for its range of functional and integrated drug discovery services, Jubilant Biosys has started the design and construction of a brand new state-of-the-art chemistry services laboratories on the existing Jubilant Greater Noida site.

Jubilant Biosys and Collaborative Drug Discovery (CDD) announced today, following an exhaustive evaluation, Jubilant has chosen CDD Vault as their discovery research informatics platform for the next 5 years.

Jubilant Biosys announced today that it has added advanced Pioneer FE system to its platform of drug discovery solutions available to customers. The Pioneer FE system from ForteBio represents the next generation SPR instrumentation for label-free characterization of biomolecules.